Extracellular regulated protein kinases play a key role via bone morphogenetic protein 4 in high phosphate-induced
Ling Qin1, Bo Tang1, Bingqing Deng1
1Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Aims:
Hyperphosphatemia is an independent risk factor of cardiovascular events in the patients with chronic kidney disease. High phosphate can induce endothelial cell apoptosis, but the exact mechanism is not clear. This study fills this knowledge gap.
Materials And Methods:
Microarray analysis was used to identify differentially expressed gene profiles in human umbilical vein endothelial cells (HUVECs) in high phosphate (3.0mM) and normal phosphate (1.0mM) medium. Microarray informatics analysis was used to explore key pathways and genes. High phosphate-induced apoptosis is marked by annexin V-FITC/PI staining and cleavage of caspase-3. Immunoblotting and quantitative real-time PCR were performed to identify the microarray analysis.
Key Findings:
Our microarray informatics analysis reveals that the mitogen-activated protein kinase (MAPK) plays a key role. As suggested by gene coexpression network analysis, bone morphogenetic protein 4 (BMP4) gene is a potential key regulatory gene in high phosphate environment. Both the expressions of BMP4 protein and mRNA are decreased. Extracellular regulated protein kinases (ERKs) are activated, while the inhibition of ERK by U0126 increases the expression of BMP4. Both recombinant BMP4 protein pretreatment and U0126 pretreatment reduce the apoptosis of endothelial cells in simulated hyperphosphatemia. However, BMP4 protein pretreatment had no effect on the activation of ERK MAPK pathway.
Significance:
Our results indicate that the inhibition of ERK MAPK pathway protects endothelial cells from apoptosis by upregulating bone morphogenetic protein 4 in endothelial cells exposed to hyperphosphatemia. Our study provides potential molecular targets for developing new strategies to reduce the endothelial cell apoptosis induced by high phosphate.
Insights
In chronic kidney disease, high phosphate induces endothelial cell apoptosis. Inhibiting ERK MAPK upregulates bone morphogenetic protein 4 (BMP4), protecting cells from hyperphosphatemia-induced damage.
Area of Science:
- Cardiovascular biology
- Endothelial cell function
- Molecular mechanisms of kidney disease
Background:
- Hyperphosphatemia is a significant risk factor for cardiovascular events in chronic kidney disease patients.
- High phosphate levels are known to induce endothelial cell apoptosis, but the underlying mechanisms require elucidation.
- Understanding these mechanisms is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the molecular mechanisms by which high phosphate induces apoptosis in human umbilical vein endothelial cells (HUVECs).
- To identify key genes and pathways involved in hyperphosphatemia-induced endothelial cell apoptosis.
- To explore potential therapeutic targets for mitigating cardiovascular risks associated with chronic kidney disease.
Main Methods:
- Microarray analysis of HUVECs cultured in high (3.0mM) versus normal (1.0mM) phosphate conditions.
- Bioinformatic analysis to identify differentially expressed genes and key signaling pathways, including MAPK.
- Validation of microarray findings using Annexin V/PI staining, caspase-3 cleavage assays, immunoblotting, and quantitative real-time PCR.
- Assessment of the role of bone morphogenetic protein 4 (BMP4) and extracellular signal-regulated kinases (ERKs) in high phosphate-induced apoptosis.
Main Results:
- Microarray analysis identified the mitogen-activated protein kinase (MAPK) pathway as critical.
- Gene coexpression network analysis suggested bone morphogenetic protein 4 (BMP4) as a key regulatory gene, with its expression decreased under high phosphate conditions.
- Extracellular regulated protein kinases (ERKs) were activated; however, inhibiting ERK with U0126 increased BMP4 expression and reduced endothelial cell apoptosis.
- Pretreatment with BMP4 protein also reduced apoptosis, but did not affect ERK MAPK activation, suggesting a parallel protective pathway.
Conclusions:
- Inhibition of the ERK MAPK pathway protects endothelial cells from hyperphosphatemia-induced apoptosis by upregulating BMP4.
- This study identifies a novel mechanism linking high phosphate, ERK MAPK, BMP4, and endothelial cell apoptosis.
- The findings provide potential molecular targets for novel therapeutic strategies to reduce endothelial cell apoptosis and cardiovascular events in chronic kidney disease.
More Related Videos
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
08:43Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Related Concept Videos
MAPK Signaling Cascades
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
TGF - β Signaling Pathway
